2006TumoriRequires access

Expression of Skp2 and p27(kip1) in cervical adenocarcinoma

Xi Wang

Open publisher page 0 citations

Abstract

Objective:To test the expressions of S phase kinase-associated protein 2 (Skp2) and cell cycle regulator p27 (kip1) in cervical adenocarcinoma. Methods:The expressions of Skp2 and p27 (kip1) were determined by tissue microarray combined with immunohistochemistry in 106 cases of cervical adenocarcinoma and 22 cases of cervical chronic inflammation. Results:The positive rate of Skp2 in cervical adenocarcinoma was 67.9%, which was significantly higher than that in cervical chronic inflammation(P0.01). The positive rate of p27(kip1) in cervical adenocarcinoma was 58.5%, which was markedly lower than that in cervical chronic inflammation(P0.05). The positive expression of Skp2 was significantly higher in G_2 and G_3 stage than in G_1 stage of cervical adenocarcinoma(P0.05). The expressions of Skp2 and p27(kip1) were related to the histologic classification. The level of Skp2 was significantly higher in endometrioid adenocarcinoma than that in other types(P0.05). The level of p27(kip1) was significantly higher in clear-cell adenocarcinoma than that in other types. There was no obviously negative correlation between the expression of Skp2 and p27 (kip1) in cervical adenocarcinoma. Conclusions:High expression of Skp2 and low expression of p27 (kip1) play an important role in the progression of cervical adenocarcinoma. Skp2 might be the one of biomolecular markers of malignancy for cervical adenocarcinoma. Tissue microarray is reliable and practical to detect the expressions of Skp2 and p27 (kip1).

About this research paper

What this paper is about

Objective:To test the expressions of S phase kinase-associated protein 2 (Skp2) and cell cycle regulator p27 (kip1) in cervical adenocarcinoma. Methods:The expressions of Skp2 and p27 (kip1) were determined by tissue microarray combined with immunohistochemistry in 106 cases of cervical adenocarcinoma and 22 cases of cervical chronic inflammation. Results:The positive rate of Skp2 in cervical adenocarcinoma was 67.9%, which was significantly higher than that in cervical chronic inflammation(P0.01). The positive rate of p27(kip1) in cervical adenocarcinoma was 58.5%, which was markedly lower than that in cervical chronic inflammation(P0.05). The positive expression of Skp2 was significantly higher in G_2 and G_3 stage than in G_1 stage of cervical adenocarcinoma(P0.05). The expressions of Skp2 and p27(kip1) were related to the histologic classification. The level of Skp2 was significantly higher in endometrioid adenocarcinoma than that in other types(P0.05). The level of p27(kip1) was significantly higher in clear-cell adenocarcinoma than that in other types. There was no obviously negative correlation between the expression of Skp2 and p27 (kip1) in cervical adenocarcinoma. Conclusions:High expression of Skp2 and low expression of p27 (kip1) play an important role in the progression of cervical adenocarcinoma. Skp2 might be the one of biomolecular markers of malignancy for cervical adenocarcinoma. Tissue microarray is reliable and practical to detect the expressions of Skp2 and p27 (kip1).

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To test the expressions of S phase kinase-associated protein 2 (Skp2) and cell cycle regulator p27 (kip1) in cervical adenocarcinoma. Methods:The expressions of Skp2 and p27 (kip1) were determined by tissue microarray combined with immunohistochemistry in 106 cases of cervical adenocarcinoma and 22 cases of cervical chronic inflammation. Results:The positive rate of Skp2 in cervical adenocarcinoma was 67.9%, which was significantly higher than that in cervical chronic inflammation(P0.01). The positive rate of p27(kip1) in cervical adenocarcinoma was 58.5%, which was markedly lower than that in cervical chronic inflammation(P0.05). The positive expression of Skp2 was significantly higher in G_2 and G_3 stage than in G_1 stage of cervical adenocarcinoma(P0.05). The expressions of Skp2 and p27(kip1) were related to the histologic classification. The level of Skp2 was significantly higher in endometrioid adenocarcinoma than that in other types(P0.05). The level of p27(kip1) was significantly higher in clear-cell adenocarcinoma than that in other types. There was no obviously negative correlation between the expression of Skp2 and p27 (kip1) in cervical adenocarcinoma. Conclusions:High expression of Skp2 and low expression of p27 (kip1) play an important role in the progression of cervical adenocarcinoma. Skp2 might be the one of biomolecular markers of malignancy for cervical adenocarcinoma. Tissue microarray is reliable and practical to detect the expressions of Skp2 and p27 (kip1).

Key concepts: SKP2, Adenocarcinoma, Malignancy, Immunohistochemistry, Medicine, Tissue microarray, Stage (stratigraphy), Cancer research

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression of Skp2 and p27(kip1) in cervical adenocarcinoma — Research Paper | ScholarLens